Gadeta Overview
- Founded
- 2015

- Status
- Private
- Employees
- 37

- Latest Deal Type
- Corporate
- Investors
- 4
Gadeta General Information
Description
Developer of innovative immunotherapies designed to treat cancer effectively. The company's innovative immunotherapies are based on the discoveries regarding the role of yo T cell receptors (TCR's) in the broad recognition of hematological and solid tumor cells and their potential use for the treatment of advanced malignancies, enabling healthcare institutions and cancer patients to eradicate both hematological and solid tumors lowering the chances of cancer.
Contact Information
- Yalelaan 62
- 3584 CM Utrecht
- Netherlands
Gadeta Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Corporate | 19-Jul-2018 | 00.000 | Completed | Generating Revenue | ||
2. Early Stage VC (Series A) | 29-Mar-2016 | 00.000 | 00.000 | Completed | Startup | |
1. Seed Round | Completed | Startup |
Gadeta Comparisons
Industry
0000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialGadeta Competitors (21)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Carisma Therapeutics | Venture Capital-Backed | Philadelphia, PA | 00 | 00000 | 00000000000 | 00000 |
000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
0000 000000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000 | 00000 |
000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
0000000 | Formerly VC-backed | Tübingen, Germany | 000 | 00.000 | 00000000 | 00.000 |
Gadeta Executive Team (7)
Gadeta Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
Giovanni Mariggi Ph.D | Medicxi | Board Member | 000 0000 |
Michèle Ollier MD | Medicxi | Board Member | 000 0000 |
Oscar Schoots Ph.D | Utrecht Holdings | Board Member | 000 0000 |
Peter Emtage | Gadeta | Board Member | 000 0000 |
Gadeta Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialGadeta Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Kite Pharma | Corporation | Majority | 000 0000 | 000000 0 | |
Baxalta Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Medicxi | Venture Capital | Minority | 000 0000 | 000000 0 | |
Utrecht Holdings | Venture Capital | Minority | 000 0000 | 000000 0 |